Bariatric surgery and T2DM improvement mechanisms: a mathematical model
暂无分享,去创建一个
[1] H. Neels,et al. Reference Values for Plasma Dipeptidyl Peptidase IV Activity and Their Association with Other Laboratory Parameters , 2001, Clinical chemistry and laboratory medicine.
[2] S. Shikora,et al. Neuro‐modulation and bariatric surgery for type 2 diabetes mellitus , 2010, International journal of clinical practice. Supplement.
[3] H. Hendriks,et al. Ghrelin response to carbohydrate-enriched breakfast is related to insulin. , 2005, The American journal of clinical nutrition.
[4] K. Cianflone,et al. Plasma acylation-stimulating protein, adiponectin, leptin, and ghrelin before and after weight loss induced by gastric bypass surgery in morbidly obese subjects. , 2003, The Journal of clinical endocrinology and metabolism.
[5] R. Gómez-Huelgas. [Bariatric surgery versus conventional medical therapy for type 2 diabetes]. , 2012, Revista clinica espanola.
[6] F. Reimann,et al. Nutritional regulation of glucagon‐like peptide‐1 secretion , 2009, The Journal of physiology.
[7] J. Holst,et al. Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus. , 1993, The Journal of clinical investigation.
[8] M. Suter,et al. Effects of Gastric Bypass and Gastric Banding on Glucose Kinetics and Gut Hormone Release , 2008, Obesity.
[9] N. Scopinaro,et al. Biliopancreatic Diversion , 1998, World Journal of Surgery.
[10] F. Rubino,et al. The effect of bilio-pancreatic diversion on type 2 diabetes in patients with BMI <35 kg/m2 , 2009, Diabetologia.
[11] I. Godsland,et al. Evaluation of four mathematical models of glucose and insulin dynamics with analysis of effects of age and obesity. , 1992, The American journal of physiology.
[12] N. Scopinaro,et al. Restoration of Acute Insulin Response in T2DM Subjects 1 Month After Biliopancreatic Diversion , 2008, Obesity.
[13] M. Nauck,et al. Reduced incretin effect in Type 2 (non-insulin-dependent) diabetes , 2006, Diabetologia.
[14] Executive Summary: Standards of Medical Care in Diabetes—2011 , 2011, Diabetes Care.
[15] J. Girard. The incretins: from the concept to their use in the treatment of type 2 diabetes. Part A: incretins: concept and physiological functions. , 2008, Diabetes & metabolism.
[16] W. Malaisse,et al. Changes in Glucagon-like Peptide-1 (GLP-1) Secretion after Biliopancreatic Diversion or Vertical Banded Gastroplasty in Obese Subjects , 2005, Obesity surgery.
[17] D. D. de Luis,et al. The effects of duodenal-jejunal exclusion on hormonal regulation of glucose metabolism in Goto-Kakizaki rats. , 2007, American journal of surgery.
[18] C. Deacon,et al. What do we know about the secretion and degradation of incretin hormones? , 2005, Regulatory Peptides.
[19] M. Rickels,et al. Narrative Review: Effect of Bariatric Surgery on Type 2 Diabetes Mellitus , 2009, Annals of Internal Medicine.
[20] Karan P. Singh,et al. Theoretical Biology and Medical Modelling , 2007 .
[21] Elan L. Ohayon,et al. A Mathematical Model of the Oral Glucose Tolerance Test Illustrating the Effects of the Incretins , 2007, Annals of Biomedical Engineering.
[22] J. Després,et al. Abdominal obesity and metabolic syndrome , 2006, Nature.
[23] E. Calle,et al. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms , 2004, Nature Reviews Cancer.
[24] M. Tschöp,et al. Ghrelin Suppresses Glucose-Stimulated Insulin Secretion and Deteriorates Glucose Tolerance in Healthy Humans , 2010, Diabetes.
[25] M. Nakazato,et al. Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. , 2000, Endocrinology.
[26] M. Ferrone,et al. Differential Effect of Weight Loss on Insulin Resistance in Surgically Treated Obese Patients. , 2006, Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition.
[27] J. Meier. The contribution of incretin hormones to the pathogenesis of type 2 diabetes. , 2009, Best practice & research. Clinical endocrinology & metabolism.
[28] Simon Hess,et al. Role for insulin signaling in catecholaminergic neurons in control of energy homeostasis. , 2011, Cell metabolism.
[29] R. Tacchino,et al. Normalization of Insulin Sensitivity in the Obese Patient after Stable Weight Reduction with Bilio-Pancreatic Diversion , 1994, Obesity surgery.
[30] J. Holst,et al. The incretin system and its role in type 2 diabetes mellitus , 2009, Molecular and Cellular Endocrinology.
[31] D. Cummings. Endocrine mechanisms mediating remission of diabetes after gastric bypass surgery , 2009, International Journal of Obesity.
[32] Francesco Rubino,et al. Is Type 2 Diabetes an Operable Intestinal Disease? , 2008, Diabetes Care.
[33] Thomas J. H. Chen,et al. Dopamine D2 receptor gene variants: association and linkage studies in impulsive-addictive-compulsive behaviour. , 1995, Pharmacogenetics.
[34] G. Mingrone,et al. Ultradian ghrelin pulsatility is disrupted in morbidly obese subjects after weight loss induced by malabsorptive bariatric surgery. , 2006, The American journal of clinical nutrition.
[35] S. Bloom,et al. Gut hormones and appetite control. , 2007, Gastroenterology.
[36] N. Volkow,et al. Decreased dopamine type 2 receptor availability after bariatric surgery: Preliminary findings , 2010, Brain Research.
[37] J. Holst,et al. GLP-1 and GIP are colocalized in a subset of endocrine cells in the small intestine , 2003, Regulatory Peptides.
[38] S. Salinari,et al. First-Phase Insulin Secretion Restoration and Differential Response to Glucose Load Depending on the Route of Administration in Type 2 Diabetic Subjects After Bariatric Surgery , 2009, Diabetes Care.
[39] V. Basevi. Standards of Medical Care in Diabetes—2011 , 2011, Diabetes Care.
[40] F. Rubino,et al. Duodenal-jejunal bypass for the treatment of type 2 diabetes in patients with body mass index of 22-34 kg/m2: a report of 2 cases. , 2007, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.
[41] E. Ferrannini,et al. Impact of Different Bariatric Surgical Procedures on Insulin Action and β-Cell Function in Type 2 Diabetes , 2009, Diabetes Care.
[42] D. D’Alessio,et al. Gastric Bypass Surgery Enhances Glucagon-Like Peptide 1–Stimulated Postprandial Insulin Secretion in Humans , 2011, Diabetes.
[43] B. Göke,et al. Gastric emptying and release of incretin hormones after glucose ingestion in humans. , 1996, The Journal of clinical investigation.
[44] Benjamin S. Aribisala,et al. Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol , 2011, Diabetologia.
[45] G. Mingrone. Role of the incretin system in the remission of type 2 diabetes following bariatric surgery. , 2008, Nutrition, metabolism, and cardiovascular diseases : NMCD.
[46] Rolf Mentlein,et al. Dipeptidyl-peptidase IV (CD26)-role in the inactivation of regulatory peptides , 1999, Regulatory Peptides.
[47] J. Holst,et al. Circadian rhythms of GIP and GLP1 in glucose-tolerant and in type 2 diabetic patients after biliopancreatic diversion , 2009, Diabetologia.
[48] M. S. Kirkman,et al. Comment on: American Diabetes Association. Standards of Medical Care in Diabetes—2011. Diabetes Care 2011;34(Suppl. 1):S11–S61 , 2011 .
[49] C. Könner. Role for insulin signaling in catecholaminergic neurons in control of energy homeostasis , 2012 .
[50] A. Mari,et al. Mechanisms of Recovery From Type 2 Diabetes After Malabsorptive Bariatric Surgery , 2006, Diabetes.
[51] J. Holst,et al. Secretion, degradation, and elimination of glucagon-like peptide 1 and gastric inhibitory polypeptide in patients with chronic renal insufficiency and healthy control subjects. , 2004, Diabetes.
[52] D. Zheng,et al. Mechanism for improved insulin sensitivity after gastric bypass surgery. , 2008, The Journal of clinical endocrinology and metabolism.
[53] E. Ghigo,et al. Neuroendocrine and metabolic effects of acute ghrelin administration in human obesity. , 2003, The Journal of clinical endocrinology and metabolism.
[54] M. Papotti,et al. Ghrelin, a natural GH secretagogue produced by the stomach, induces hyperglycemia and reduces insulin secretion in humans. , 2001, The Journal of clinical endocrinology and metabolism.
[55] E. Verspohl. Novel therapeutics for type 2 diabetes: incretin hormone mimetics (glucagon-like peptide-1 receptor agonists) and dipeptidyl peptidase-4 inhibitors. , 2009, Pharmacology & therapeutics.
[56] J. Marescaux,et al. Effect of Duodenal–Jejunal Exclusion in a Non-obese Animal Model of Type 2 Diabetes: A New Perspective for an Old Disease , 2004, Annals of surgery.
[57] H. Kwon,et al. Early Changes in Incretin Secretion After Laparoscopic Duodenal–Jejunal Bypass Surgery in Type 2 Diabetic Patients , 2010, Obesity surgery.
[58] Thomas D. Giles,et al. Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss , 2006, Arteriosclerosis, thrombosis, and vascular biology.
[59] G. Dohm,et al. A new paradigm for type 2 diabetes mellitus: could it be a disease of the foregut? , 1998, Annals of surgery.
[60] Yuxiang Sun,et al. Central and Peripheral Roles of Ghrelin on Glucose Homeostasis , 2007, Neuroendocrinology.
[61] J. Egan,et al. Human duodenal enteroendocrine cells: source of both incretin peptides, GLP-1 and GIP. , 2006, American journal of physiology. Endocrinology and metabolism.
[62] E. Dellinger,et al. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. , 2002, The New England journal of medicine.
[63] T. Hansen,et al. Insulin resistance: interactions between obesity and a common variant of insulin receptor substrate-1 , 1995, The Lancet.
[64] J. Teixeira,et al. Do Incretins Play a Role in the Remission of Type 2 Diabetes after Gastric Bypass Surgery: What are the Evidence? , 2009, Obesity surgery.
[65] San-yuan Hu,et al. Ileal Transposition Controls Diabetes as Well as Modified Duodenal Jejunal Bypass With Better Lipid Lowering in a Nonobese Rat Model of Type II Diabetes by Increasing GLP-1 , 2008, Annals of surgery.
[66] J. Teixeira,et al. Weight loss and incretin responsiveness improve glucose control independently after gastric bypass surgery , 2010, Journal of diabetes.
[67] K. Blum,et al. Neuro-Genetics of Reward Deficiency Syndrome (RDS) as the Root Cause of "Addiction Transfer": A New Phenomenon Common after Bariatric Surgery. , 2011, Journal of genetic syndromes & gene therapy.
[68] J. Girard,et al. Physiology of incretins (GIP and GLP-1) and abnormalities in type 2 diabetes. , 2008, Diabetes & metabolism.
[69] D. Cummings,et al. Role of the bypassed proximal intestine in the anti-diabetic effects of bariatric surgery. , 2007, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.
[70] R. Batterham,et al. Gut Hormone Profiles Following Bariatric Surgery Favor an Anorectic State, Facilitate Weight Loss, and Improve Metabolic Parameters , 2006, Annals of surgery.
[71] R. Seeley,et al. Bypassing the duodenum does not improve insulin resistance associated with diet-induced obesity in rodents , 2010 .
[72] J. Teixeira,et al. Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes. , 2008, The Journal of clinical endocrinology and metabolism.
[73] W. Pories,et al. Who Would Have Thought It? An Operation Proves to Be the Most Effective Therapy for Adult‐Onset Diabetes Mellitus , 1995, Annals of surgery.
[74] J. Marescaux,et al. The Mechanism of Diabetes Control After Gastrointestinal Bypass Surgery Reveals a Role of the Proximal Small Intestine in the Pathophysiology of Type 2 Diabetes , 2006, Annals of surgery.
[75] A. Baron,et al. Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery. , 2005, The New England journal of medicine.
[76] J. Holst,et al. Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus. , 2003, The Journal of clinical endocrinology and metabolism.
[77] J. Holst. The physiology of glucagon-like peptide 1. , 2007, Physiological reviews.
[78] B. Wolfe,et al. Bariatric surgery: a review of procedures and outcomes. , 2007, Gastroenterology.
[79] D. Drucker. The role of gut hormones in glucose homeostasis. , 2007, The Journal of clinical investigation.
[80] J. Holst,et al. Exaggerated glucagon-like peptide-1 and blunted glucose-dependent insulinotropic peptide secretion are associated with Roux-en-Y gastric bypass but not adjustable gastric banding. , 2007, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.
[81] M. Gagner,et al. The Early Effect of the Roux-en-Y Gastric Bypass on Hormones Involved in Body Weight Regulation and Glucose Metabolism , 2004, Annals of surgery.
[82] B. Bistrian,et al. Rapid Communication Circulating Ghrelin Concentrations Are Lowered by Intravenous Glucose or Hyperinsulinemic Euglycemic Conditions in Rodents , 2022 .
[83] M. Berger,et al. Effects of fish oil on the neuro-endocrine responses to an endotoxin challenge in healthy volunteers. , 2007, Clinical nutrition.
[84] M. Schambelan,et al. Improvement in Peripheral Glucose Uptake After Gastric Bypass Surgery Is Observed Only After Substantial Weight Loss Has Occurred and Correlates with the Magnitude of Weight Lost , 2009, Journal of Gastrointestinal Surgery.
[85] G. Mingrone,et al. Mechanisms of early improvement/resolution of type 2 diabetes after bariatric surgery. , 2009, Diabetes & metabolism.
[86] J. Marescaux,et al. The role of the small bowel in the regulation of circulating ghrelin levels and food intake in the obese Zucker rat. , 2005, Endocrinology.
[87] J. Holst,et al. Incretins, insulin secretion and Type 2 diabetes mellitus , 2004, Diabetologia.
[88] D. Drucker,et al. Biology of incretins: GLP-1 and GIP. , 2007, Gastroenterology.
[89] Mats O Karlsson,et al. An Integrated Glucose‐Insulin Model to Describe Oral Glucose Tolerance Test Data in Healthy Volunteers , 2010, Journal of clinical pharmacology.